Krabbendam, L.

cannabi cannabis use patient psychosi effect schizophrenia disorder interaction study group genotype winkel psychiatry lifetime outcome akt 1 performance onset sample van winkel cognition measure investigator cidi lifetime use alteration association control cannabis-induced urinalysi analysis university period eli lilly health accuracy assessment reaction memory analyses attention result sibling evidence moderation sensitivity analysis research sensitivity akt 1 genotype european graduate school research grant holder cannabis-using henquet cpt reaction time t /t genotype absence symposium speaker finding grant reaction time netherland addition family illness onset 12 months cannabis-using patients prefrontal department maastricht schizophr neuroscience centre illness symptom table receptor yucel change level school month